Source comparison
Melanotan-2 60s Age Specific Protocol Comparison
Starting Dose 250–500 mcg 50–100 mcg Lower starting dose essential. Renal clearance reduced by 30–50% in this age group, extending half-life significantly Titration Timeline 7–10 days to maintenance 21–28 days to maintenance Extended timeline allows cardiovasc
This comparison does not assign a generated winner or score.
- Starting Dose
- 250–500 mcg
- 50–100 mcg
- Lower starting dose essential. Renal clearance reduced by 30–50% in this age group, extending half-life significantly
- Titration Timeline
- 7–10 days to maintenance
- 21–28 days to maintenance
- Extended timeline allows cardiovascular adaptation and accurate assessment of dose-response without compounding effects
- Maintenance Dose
- 1–2 mg daily or EOD
- 300–500 mcg 2–3x weekly
- Lower total weekly exposure achieves equivalent pigmentation with dramatically reduced sympathetic load
- Cardiovascular Monitoring
- Optional
- Mandatory at each escalation
- BP and HR monitoring catches hypertensive responses early. Essential given 63% baseline hypertension prevalence over age 65
- Reconstitution Concentration
- 1 mg/mL standard
- 2 mg/mL recommended
- Higher concentration allows accurate measurement of sub-100 mcg doses using standard insulin syringes
- Contraindications
- Pregnancy, melanoma history
- Add: GFR <45, uncontrolled HTN, recent MI, Stage 3+ heart failure
- Age-related cardiovascular conditions create absolute contraindications not present in younger populations